Since our founding in 2000, ev3 has been dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of peripheral vascular and neurovascular diseases, a strategy that we believe is uncommon in the medical device industry. Our products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. We offer a comprehensive portfolio of treatment options, including the primary interventional technologies used today – peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, emb
ev3 to Present at the Barclays Capital 2010 Global Healthcare Conference on March 23, 2010 - 03/16/10
PLYMOUTH, Minn., Mar 16, 2010 (GlobeNewswire via COMTEX) -- ev3 Inc. (Nasdaq:EVVV) today announced that Julie Tracy, senior vice president and chief communications officer, is scheduled to present at the Barclays Capital 2010 Global Healthcare Conference at 4:15 p.m. Eastern Time on Tuesday, March 2... More >>
ev3 Reports 2009 Fourth Quarter and Full-Year Financial Results and 2010 Guidance - 02/18/10
Fourth Quarter Net Product Sales Increase to $126.8 Million; 16% Constant Currency Growth
Fourth Quarter GAAP EPS Reaches $0.12
Cash and Cash Equivalents Increase to $98.1 Million
PLYMOUTH, Minn., Feb. 18, 2010 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV), a global endovascular device c... More >>
ev3 Inc. to Report 2009 Fourth Quarter and Full-Year Financial Results and Host Conference Call on February 18, 2010 - 02/11/10
PLYMOUTH, Minn., Feb 11, 2010 (GlobeNewswire via COMTEX) -- ev3 Inc. (Nasdaq:EVVV) will release its 2009 fourth quarter and full-year financial results and its financial guidance for 2010 on Thursday, February 18, 2010, before regular market trading hours.
The company will host a conference call an... More >>
ev3 Announces Completion of Voluntary Recall - 01/06/10
PLYMOUTH, Minn., Jan 6, 2010 (GlobeNewswire via COMTEX) -- ev3 Inc. (Nasdaq:EVVV) today announced that a voluntary Class I recall of the TrailBlazer Support Catheter was completed in December 2009, and all affected units are in the company's possession.
On January 5, 2010, the U.S. Food & Drug... More >>
ev3 to Present at the 28th Annual J.P. Morgan Healthcare Conference on January 12, 2010 - 01/05/10
PLYMOUTH, Minn., Jan 5, 2010 (GlobeNewswire via COMTEX) -- ev3 Inc. (Nasdaq:EVVV) today announced that Robert Palmisano, president and chief executive officer, is scheduled to present at the 28th Annual J.P. Morgan Healthcare Conference at 11:30 a.m. Pacific Time on Tuesday, January 12, 2010 at the ... More >>
ev3 Announces Promotion of Two Senior Executives - 12/15/09
Pascal Girin Named Executive Vice President and Chief Operating Officer; David Mowry Named Senior Vice President and President, Worldwide NeurovascularPLYMOUTH, Minn., Dec 15, 2009 (GlobeNewswire via COMTEX) -- ev3 Inc. (Nasdaq:EVVV) today announced the promotion of two executives effective January ... More >>
ev3 Inc. to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 - 11/24/09
PLYMOUTH, Minn., Nov 24, 2009 (GlobeNewswire via COMTEX) -- ev3 Inc. (Nasdaq:EVVV) today announced that Shawn McCormick, senior vice president and chief financial officer, is scheduled to present at the Piper Jaffray 21st Annual Health Care Conference at 8:30 a.m. Eastern Time on Tuesday, December 1... More >>
ev3 Inc. to Present at the 2009 Citi Investment Research Small and Mid Cap Conference on November 19, 2009 - 11/12/09
PLYMOUTH, Minn., Nov. 12, 2009 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV) today announced that Julie Tracy, senior vice president and chief communications officer, is scheduled to present at the 2009 Citi Investment Research Small/Mid Cap Conference at 11:20 a.m. Eastern Time on Thursday, November 1... More >>
ev3 Reports 2009 Third Quarter Financial Results - 10/27/09
Third Quarter Net Product Sales Increase to $112.8 million;
15% Constant Currency Growth
Third Quarter GAAP EPS Reaches $0.06
Full-Year 2009 Revenue and Earnings Guidance Increased
PLYMOUTH, Minn., Oct. 27, 2009 (GLOB... More >>
ev3 Inc. to Report 2009 Third Quarter Results and Host Conference Call on October 27, 2009 - 10/20/09
PLYMOUTH, Minn., Oct. 20, 2009 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV) will release its 2009 third quarter financial results on Tuesday, October 27, 2009, before regular market trading hours.
The company will host a conference call and webcast the same day at 7:30 a.m. Central Time (8:30 a.m... More >>
Q1 2010 ev3 Inc. Earnings Conference Call (Tentative)
March 2010
Help
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
